Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Data Management & Biostatistics 3 Key Takeaways on Choosing the Right Committee for Medical Device Trials By Livia Hlavackova February 28, 2019 Medical and Regulatory Affairs Brexit is Pressuring Sponsors. Here’s How We’re Responding. By Premier Research February 20, 2019 Clinical ResearchPhase 1 - Phase 4 Data Protection Part 1: Understanding How GDPR Affects Clinical Trials By Victoria Watts February 12, 2019 Clinical ResearchPhase 1 - Phase 4 Understanding Recent Updates to the Classification of Rosacea By Marlis Sarkany January 9, 2019 Clinical ResearchPhase 1 - Phase 4 Picking Neuropathic Pain Trial Sites? Look for Experience — Among Other Things By Scott Millard December 26, 2018 Consulting Parkinson’s: Why Has Disease Modification Failed — and What Now? By Andreas Schreiner December 19, 2018 Previous 1 …25 26 27 28 29 … 56 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today